Healthcare & Life Sciences
Rigontec
Germanyrigontec.com
Rigontec is a startup based in Germany, most recent round Series B, 4 tracked investors.
activeseries-b
series-b
Stage
4
Investors
About Rigontec
Rigontec is a company headquartered in Germany. Its most recent tracked round is Series B. Brouky records 4 investors associated with the company.
Rigontec develops RNA-based immunotherapies designed to activate the immune system to target and destroy cancer cells.
Explore Rigontec's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.